全文获取类型
收费全文 | 2617篇 |
免费 | 194篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 66篇 |
妇产科学 | 64篇 |
基础医学 | 296篇 |
口腔科学 | 129篇 |
临床医学 | 252篇 |
内科学 | 613篇 |
皮肤病学 | 67篇 |
神经病学 | 152篇 |
特种医学 | 55篇 |
外科学 | 438篇 |
综合类 | 12篇 |
预防医学 | 320篇 |
眼科学 | 19篇 |
药学 | 190篇 |
中国医学 | 12篇 |
肿瘤学 | 117篇 |
出版年
2023年 | 16篇 |
2022年 | 28篇 |
2021年 | 69篇 |
2020年 | 37篇 |
2019年 | 73篇 |
2018年 | 84篇 |
2017年 | 61篇 |
2016年 | 56篇 |
2015年 | 79篇 |
2014年 | 90篇 |
2013年 | 117篇 |
2012年 | 189篇 |
2011年 | 170篇 |
2010年 | 107篇 |
2009年 | 85篇 |
2008年 | 113篇 |
2007年 | 140篇 |
2006年 | 157篇 |
2005年 | 142篇 |
2004年 | 99篇 |
2003年 | 117篇 |
2002年 | 80篇 |
2001年 | 56篇 |
2000年 | 66篇 |
1999年 | 60篇 |
1998年 | 24篇 |
1997年 | 25篇 |
1996年 | 25篇 |
1995年 | 19篇 |
1994年 | 19篇 |
1993年 | 16篇 |
1992年 | 34篇 |
1991年 | 33篇 |
1990年 | 47篇 |
1989年 | 32篇 |
1988年 | 19篇 |
1987年 | 26篇 |
1986年 | 19篇 |
1985年 | 11篇 |
1984年 | 25篇 |
1983年 | 17篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 8篇 |
1975年 | 10篇 |
1974年 | 8篇 |
1973年 | 10篇 |
1967年 | 6篇 |
排序方式: 共有2821条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
Bruna Souza Felix Bravo Laila Klotz De Almeida Balassiano Camila Roos Mariano Da Rocha Carolina Barbosa De Sousa Padilha Carolina Martinezt Torrado Roberta Teixeira Da Silva Jo?o Carlos Regazzi Avelleira 《The Journal of clinical and aesthetic dermatology》2015,8(12):42-47
The growing use of dermal fillers, specifically the use of hyaluronic acid, can be explained by their effectiveness and versatility as well as their favorable safety profiles. Nevertheless, early and late complications with varying levels of severity may occur. The incidence of complications is low and the majority of adverse events are mild (edema, erythema, and local ecchymosis) and of limited duration. However, more severe events, such as ischemia and necrosis, may occur. The symptoms of ischemia can occur immediately after the injection or several hours after the procedure. Here, the authors report three cases of necrosis after hyaluronic acid injection with the first symptoms presenting only several hours after the procedure. The patients were treated immediately after the diagnosis. The aim of this review is to communicate the possibility of the delayed-type presentation of necrosis, present the signs and symptoms that lead to early diagnosis, and review the treatment possibilities of this severe complication.Dermal fillers have been injected with increasing frequency over the past three decades for soft-tissue augmentation by volume expansion in the management of the aging face. In 2012, there were about two million procedures using dermal fillers, according to the American Society of Plastic Surgeons, five percent more than in 2011 and 205 percent more than in 2000, second only to botulinum toxin type A. These minimally invasive and nonsurgical cosmetic procedures were the two most commonly performed in this range of time studied.1,2The growing use of dermal fillers, specifically the use of hyaluronic acid (HA), can be explained by their effectiveness and versatility as well as their favorable safety profiles. Nevertheless, early and late complications with varying levels of severity may occur. The incidence of complications is low and the majority of adverse events are mild (edema, erythema, and local ecchymosis) and of limited duration. However, more severe events, such as ischemia and necrosis, may occur.Injection necrosis is a rare, but important, complication associated with dermal fillers. Necrosis can be attributed to one of two factors—an interruption of vascular supply due to compression or frank obstruction of vessels by direct injection of the material into a vessel itself. The glabella is the injection site commonly believed to be at greater risk for necrosis, but it can also occur at the nasolabial fold.3 Risk factors for intravascular injection include site of application (deep injection of filler products at or near the site of named vessels), volume applied (larger amounts of product can cause a proportionally greater degree of arterial obstruction), and previous scarring (deep tissue scars may stabilize and fix arteries in place, making them easier to penetrate with small sharp needles).4The initial presentation of vascular events may include pain and discomfort disproportionate to what is typically experienced following filler treatments and clinical findings, including blanching, livedo pattern, or violaceous discoloration.4 Although many cases report this immediate post-injection presentation as the typical background seen in a necrosis event, there are few reports with the first symptom presenting only hours after augmentation. See Figures 1 through through3,3, where the authors present three cases of vascular compromise after soft-tissue augmentation with delayed-type presentation.
Open in a separate windowOpen in a separate windowFigures 2Aand 2B.Case 2: Necrosis and secondary infection 48 hours after the HA injection (a). Discrete scars in the affected area after treatment (b).
Open in a separate windowOpen in a separate windowFigures 1Aand 1B.Case 1: Edema, erythema, and progressive violaceous reticulated patch, livedoid area were observed on the left cheek 36 hours after the injection (a). Complete healing five days after hyaluronidase application and nine days after the HA injection (b).
Open in a separate windowOpen in a separate windowFigures 3Aand 3B.Case 3: Necrosis and secondary infection 48 hours after the HA injection (a). Erythema, hipercromia, and discreet scars in the affected area after treatment (b). 相似文献
36.
37.
Virginia Balouz María de los Milagros Cámara Gaspar E. Cánepa Santiago J. Carmona Romina Volcovich Nicolás Gonzalez Jaime Altcheh Fernán Agüero Carlos A. Buscaglia 《Clinical and Vaccine Immunology : CVI》2015,22(3):304-312
The trypomastigote small surface antigen (TSSA) is a mucin-like molecule from Trypanosoma cruzi, the etiological agent of Chagas disease, which displays amino acid polymorphisms in parasite isolates. TSSA expression is restricted to the surface of infective cell-derived trypomastigotes, where it functions as an adhesin and engages surface receptors on the host cell as a prerequisite for parasite internalization. Previous results have established TSSA-CL, the isoform encoded by the CL Brener clone, as an appealing candidate for use in serology-based diagnostics for Chagas disease. Here, we used a combination of peptide- and recombinant protein-based tools to map the antigenic structure of TSSA-CL at maximal resolution. Our results indicate the presence of different partially overlapping B-cell epitopes clustering in the central portion of TSSA-CL, which contains most of the polymorphisms found in parasite isolates. Based on these results, we assessed the serodiagnostic performance of a 21-amino-acid-long peptide that spans TSSA-CL major antigenic determinants, which was similar to the performance of the previously validated glutathione S-transferase (GST)-TSSA-CL fusion molecule. Furthermore, the tools developed for the antigenic characterization of the TSSA antigen were also used to explore other potential diagnostic applications of the anti-TSSA humoral response in Chagasic patients. Overall, our present results provide additional insights into the antigenic structure of TSSA-CL and support this molecule as an excellent target for molecular intervention in Chagas disease. 相似文献
38.
39.
Suzanne E. Mitchell Morgan Mako Ekaterina Sadikova Linda Barnes Abriella Stone Milagros C. Rosal John Wiecha 《Journal of diabetes science and technology》2014,8(6):1185-1192
The purpose was to characterize participants’ experiences of a diabetes self-management (DSM) education program delivered via a virtual world (VW) versus a face-to-face (F2F) format. Participants included a randomly selected sample of participants who completed the Women in Control study. Four focus groups were conducted with 32 participants. Four researchers coded the data and conducted a qualitative thematic analysis. Four overarching themes were identified. Three domains apply to both VW and F2F formats, including (1) the value of DSM knowledge gained, (2) cultivating DSM attitudes and skills, and (3) the value of peer-derived social support. The fourth domain is labeled positive technological development for DSM (VW condition only). VW and F2F groups both reported mastery of DSM knowledge, attitudes, and skills, and there were no differences in peer-derived social support between groups. The technological aspects of VW participation afforded VW participants a unique sense of personal agency and diabetes self-efficacy not reported by F2F participants. DSM education in a VW is feasible and educational outcomes are similar to a F2F classroom experience. Furthermore, learning DSM skills in a VW offers unique advantages in supporting personal agency for health behavior change. Further research is warranted. 相似文献
40.